13.4 Delivery of Drugs

Why “we’ll send it” is still dispensing

Quick Answer: A Connecticut pharmacy may mail or deliver a dispensed drug to the patient. CGS § 20-612a requires valid photographic identification before releasing a controlled substance to a person not known to the pharmacist (exceptions: institutional, LTCF, assisted living, hospital). Central fill is Chapter 17. Shipping into Connecticut from outside the state requires a nonresident pharmacy certificate (CGS §§ 20-627, 20-628; Chapter 18). Keep manufacturer storage (including temperature) and, for CS mailed by a DEA registrant, a plain outer wrapper. Connecticut has not published a unique “signature required on every CS delivery” statute.

NABP Competency 4.3 is delivery. The fill is not finished when the vial is labeled. It is finished when the right person receives the right package under the right storage conditions. Candidates lose this item by treating a neighbor’s pickup of oxycodone as a cashier problem, by assuming Connecticut bans mailing CS, or by thinking a Florida.com pharmacy may ship metformin into Hartford with only a Florida license.

CGS § 20-612 still says only a pharmacy may accept a prescription for dispensing. Delivery does not let a grocery locker, a ride-share driver acting as a pop-up pharmacy, or an unregistered website become the dispenser. The licensed pharmacy dispenses; a courier is a carrier, not a second pharmacy — unless that other site is itself a licensed central dispensing or nonresident pharmacy.

Mailing and delivery to the patient

Connecticut Chapter 400j does not prohibit a resident pharmacy from mailing or delivering a filled prescription to the patient or the patient’s representative. Mail-order is a method of delivery, not a separate practice act. The same labeling (§ 20-617), packaging (PPPA), counseling-offer (§ 20-614(d) written/telephone substitute when the patient is not at the window — Chapter 11), and controlled-substance rules still apply.

Temperature and integrity. Manufacturer labeling and USP storage statements travel with the product. A reconstituted antibiotic, insulin, or other labeled refrigerated item cannot sit in a summer mailbox as if it were lisinopril. Connecticut’s central dispensing regulation is explicit even though that model is Chapter 17: RCSA § 20-576-77(c) requires shipment in accordance with manufacturer labeling, and § 20-576-77(h) requires containers and processes that keep stability and potency, including appropriate temperature range throughout shipping and tamper-evident packaging. That is the operational standard to copy for ordinary delivery even when the pharmacy is not using a central-fill contractor: if the label says 2–8 °C, the parcel has to honor it.

Signature. Connecticut has not published a statewide rule that every controlled-substance delivery requires a wet signature. Carrier policies (adult signature, photo on delivery) and professional judgment still matter, especially for CS and for refrigerated product. Do not invent a CGS section number for “signature on all CS mail.” If a stem cites a carrier’s adult-signature requirement, follow the stem; if it asks what Connecticut publishes, the honest answer is that § 20-612a is a release-of-CS identification rule, not a parcel-signature statute.

Controlled substances in the mail. A DEA-registered pharmacy may mail CS to a patient. Inner packaging must be labeled as required (section 13.2). The outer wrapper must not indicate that the contents are a controlled substance — no “oxycodone” on the shipping label, no CS stickers on the carton. That USPS/DEA outer-wrapper practice is how diversion-by-porch-pirate is limited without advertising the vial. Connecticut has not published a separate numeric “no more than X days of CS by mail” cap. Ordinary CS quantity, corresponding-responsibility, and opioid 7-day / 5-day first-fill rules (Chapter 9) still apply to what is mailed; they are not rewritten as a postal regulation.

Agent pickup and photographic ID — CGS § 20-612a

CGS § 20-612a is the counter-and-agent rule: a pharmacist licensed under Chapter 400j or his or her agent shall require the presentation of valid photographic identification prior to releasing a controlled substance to any person not known to such pharmacist. The section does not apply in an institutional setting or to a long-term care facility, including an assisted living facility or a hospital.

Exam mechanics:

• Not known is the trigger. The regular patient the pharmacist actually recognizes is not forced through a driver’s-license ritual every Tuesday. A new face — neighbor, Uber driver, cousin — is.
• The ID duty applies to controlled substances, not to every noncontrolled refill. Professional judgment can still ask for ID on a suspicious noncontrolled pickup; the statute is CS.
• An agent of the pharmacist (technician, intern, clerk handing out completed bags) may be the person who asks for the ID. The standard is still the pharmacist’s knowledge of the person. “The cashier didn’t recognize him and didn’t ask” is a § 20-612a miss.
• Institutional / LTCF / ALF / hospital pickups inside those settings are excepted. A community pharmacy delivering into an LTCF is a different workflow (often a facility-control medication pass), not a street-corner unknown-person release.
• ID is not a substitute for corresponding responsibility (Chapter 12). A perfect driver’s license on a forged oxycodone blank is still a refusal problem.

A working list before the bag leaves:

• Is the product controlled? If yes and the person is not known, photo ID (§ 20-612a).
• Is the person the patient or an agent? Counseling offer may need the written/telephone substitute (Chapter 11).
• Is this mail/delivery? Confirm address, storage (refrigerate / do not freeze / room temperature), and plain outer wrap if CS.
• Is another pharmacy doing the fill? Central fill (below) or nonresident (below) — wrong chapter is a wrong license.

Central fill — teaser for Chapter 17

RCSA §§ 20-576-74 through 20-576-79 (effective February 18, 2022) define shared pharmacy services. A central dispensing pharmacy is a licensed pharmacy acting as agent of, or under contract with, an originating pharmacy. That is not a prescription transfer under section 13.1. The prescription still belongs to the originating relationship; another licensed pharmacy is performing dispensing steps.

Delivery-relevant slices only (full model is Chapter 17):

• RCSA § 20-576-77(b): label, or include with the dispensed prescription, the name, address, and telephone number of both the originating pharmacy and the central dispensing pharmacy, plus all CGS § 20-617 information.
• § 20-576-77(h): temperature control during storage and shipping; tamper-evident packaging.
• § 20-576-77(i): the central dispensing pharmacy may ship or deliver directly to the patient or patient’s representative after final verification by a central dispensing pharmacist, if requested.

Federal CS central-fill labels still need the retail name/address and the central fill DEA unique identifier (21 CFR 1306.14(b) / 1306.24(b)). Do not treat central fill as an unregistered basement. Do not treat it as a nonresident mail-order either — that is a different credential.

Nonresident shipping into Connecticut — teaser for Chapter 18

CGS § 20-627(a) defines nonresident pharmacy: any pharmacy located outside this state that ships, mails, or delivers, in any manner, legend devices or legend drugs into this state pursuant to a prescription order. § 20-627(b) requires registration with DCP upon approval of the Commission, plus an annual officer/pharmacist report, ten-day change reports, home-state licensure, inspection reports, sterile-compounding disclosures, a toll-free pharmacist number with all-times access to the patient’s records printed on each Connecticut container, discipline reporting, and 24-hour recall contact lists. CGS § 20-628 is the prohibition on doing that shipping business without the certificate.

A Manchester, New Hampshire mail-order pharmacy filling a Hartford patient’s maintenance drugs is not excused because it is legal in New Hampshire. It needs the Connecticut nonresident credential. Facility hours, manager, and inspection details are Chapter 18. This chapter only needs the delivery hook: shipping into Connecticut is a Connecticut registration event.

Realistic Connecticut scenarios

A technician in a New London community pharmacy hands a completed alprazolam bag to a man she has never seen, who says he is the patient’s brother. § 20-612a requires valid photographic identification because the person is not known to the pharmacist. Waving him through because “family always picks up” is the statute’s fact pattern.

A West Hartford pharmacy offers free delivery of a reconstituted amoxicillin suspension. The SIG and manufacturer label require refrigeration. Putting the bottle in an uninsulated satchel on an 85-degree afternoon is a storage failure — the same professional duty § 20-576-77 spells out for central-fill shipping. The delivery driver is not a second pharmacist; the dispensing pharmacy still owns the product until it is received under proper conditions.

A Florida corporation mails 90-day bottles of atorvastatin into Stamford with no Connecticut nonresident file. § 20-627 names that business. Home-state licensure is necessary and not sufficient. The Connecticut container still needs the toll-free pharmacist line (§ 20-627(b)(7)) and the § 20-617 label elements.

Official anchors

• CGS § 20-612a — photographic identification before releasing a CS to a person not known to the pharmacist.
• CGS §§ 20-627, 20-628 — nonresident pharmacy definition, registration, toll-free label; shipping without a certificate.
• RCSA § 20-576-77 — central dispensing label, manufacturer-label shipping, temperature, optional direct-to-patient delivery (Chapter 17).
• CGS § 20-617 — label elements that still apply when the vial is mailed.